Menu

Tango Therapeutics, Inc. TNGX

Full chart Compare
Set alert

Price alert · TNGX

All alert types
24.30 USD +1.56 (+6.86%)

At closeNov 10, 2026, 4:52 PM EST

24.30 0.00 0.00%

After hours · Nov 10, 4:52 PM ET

22.38 Day range 24.65
7.49 52-week range 34.39
YTD
+174.27%
1 year
+206.43%

Revenue & Expenses

Other Income → Expenses: $9.70MOther Operating Income → Expenses: $2.28MExpenses → Selling, General & Admin: $41.51MExpenses → Research & Development: $132.16MGross Profit → Expenses: $60.10MRevenue → Gross Profit: $60.10MRevenue → Cost of Revenue: $2.28MNet Loss → Expenses: $101.59MOther Income$9.70MOther Operating Income$2.28MGross Profit$60.10MNet Loss$101.59MCost of Revenue$2.28MExpenses$173.68MSelling, General & Admin$41.51MResearch & Development$132.16MRevenue$62.38M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

TNGX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
62.38M42.07M36.53M24.86M37.04M
62.38M42.07M36.53M24.86M37.04M
62.38M42.07M36.53M24.86M37.04M
173.67M187.66M150.70M135.93M95.23M
132.16M143.92M115.20M105.91M77.64M
41.51M43.75M35.50M30.02M17.60M
-111.29M-145.59M-114.17M-111.07M-58.19M
4.00K208.00K134.00K54.00K292.00K
-101.59M-130.30M-101.74M-108.18M-58.23M
-101.59M-130.30M-101.74M-108.18M-58.23M
-101.59M-130.30M-101.74M-108.18M-58.23M
-101.59M-130.30M-101.74M-108.18M-58.23M
-0.87-1.19-1.08-1.23-0.94
-0.87-1.19-1.08-1.23-0.94
-0.87-1.19-1.08-1.23-0.94
-101.59M-130.09M-101.61M-108.12M-57.94M
-101.59M-130.09M-101.61M-108.12M-57.94M
116.17M109.23M94.57M87.82M62.11M
116.17M109.23M94.57M87.82M62.11M